ArticleCancers2023

Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease.

Vladimir Gerov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.